2C62

ICD-11 MMS 2026-01

Inflammatory carcinoma of breast

Description

An advanced, invasive breast adenocarcinoma characterised by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Inflammatory carcinoma of breast
  • Inflammatory adenocarcinoma of breast

Exclusions from above levels

  • 2B56.2 – Angiosarcoma of breast
  • 2E0Y – Nipple metastasis
  • http://id.who.int/icd/entity/1706880799 – Malignant neoplasm of skin of breast
Show allHide
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2C60 – Carcinoma of breast, specialised type
  • 2C61 – Invasive carcinoma of breast
  • 2C63 – Malignant phyllodes tumour of breast
  • 2C64 – Solid papillary carcinoma of breast with evidence of invasion
  • 2C65 – Hereditary breast and ovarian cancer syndrome
  • 2C6Y – Other specified malignant neoplasms of breast
  • 2C6Z – Malignant neoplasms of breast, unspecified

Foundation entity

Inflammatory carcinoma of breast – http://id.who.int/icd/entity/986359233

Allowed postcoordination axes

Part of: 02: Neoplasms